What will the price of bngo stock be in 2022?
Our BNGO stock forecast indicates that BioNano Genomics, Inc. shares will see a -25.80% price decrease over the next month and reach a price of $ 1.32 by April 12, 2022. What will the price of BNGO stock be next year?
What is the price prediction for BioNano Genomics Inc (bngo) stock?
Bionano Genomics Inc quote is equal to 2.020 USD at 2022-03-03. Based on our forecasts, a long-term increase is expected, the "BNGO" stock price prognosis for 2027-02-26 is 12.530 USD.
How often do you update the bngo stock projections?
"BNGO" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "BNGO" projections. At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Bionano Genomics Inc (BNGO).
Should you invest in bngo shares?
Our Ai stock analyst implies that there will be a positive trend in the future and the BNGO shares might be good for investing for making money. Since this share has a positive outlook we recommend it as a part in your portfolio.
How much will BNGO be worth?
Bionano Genomics Inc quote is equal to 1.820 USD at 2022-07-22. Based on our forecasts, a long-term increase is expected, the "BNGO" stock price prognosis for 2027-07-16 is 3.431 USD. With a 5-year investment, the revenue is expected to be around +88.54%. Your current $100 investment may be up to $188.54 in 2027.
Is BNGO a strong buy?
5 = Strong Sell, . 5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy)....Consensus Analyst Price Target.High Prediction$12.00Low Prediction$7.001 more row
Is BNGO a Buy Sell or Hold?
Bionano Genomics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Why is BNGO a good buy?
Bionano (BNGO) made solid progress with its business last year. It is building a robust ecosystem with a recurring revenue outlook. Potential risks remain, but BNGO stock still has upside potential.
Is BNGO expected to rise?
Bionano Genomics Inc (NASDAQ:BNGO) The 3 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 8.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +357.14% increase from the last price of 1.75.
Is BNGO undervalued?
BNGO fair value BNGO ($1.82) is undervalued by... subscribe to Premium to read more.
Is BNGO a pump and dump?
BNGO stock has suffered at the hands of a Ritalin-using pump and dump scheme making waves in 2021.
What type of stock is BNGO?
Bionano (BNGO) is a life sciences company looking to make an impact in the cytogenetics space – that is in the study of chromosomes. This it is planning to do via its OGM (optical genome mapping) system Saphyr.
How good is Bionano?
Bionano Genomics has an overall rating of 4.0 out of 5, based on over 33 reviews left anonymously by employees. 71% of employees would recommend working at Bionano Genomics to a friend and 48% have a positive outlook for the business. This rating has been stable over the past 12 months.
Why is BNGO dropping?
BNGO Bionano Genomics is falling or rising technical reasons Look for opportunities to sell or SHORT Bionano Genomics BNGO at this time. Stock is falling and might fall more. It appears as if Bionano Genomics BNGO gave a large move recently.
Is BNGO a pump and dump?
BNGO stock has suffered at the hands of a Ritalin-using pump and dump scheme making waves in 2021.
What does BNGO company do?
The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics.
How many outstanding shares does BNGO have?
289.7MShare StatisticsAvg Vol (3 month) 36.29MShares Outstanding 5289.7MImplied Shares Outstanding 6N/AFloat 8284.1M% Held by Insiders 11.92%7 more rows
Has Bionano applied for FDA approval?
The Food and Drug Administration has not yet approved the device for use as a medical diagnostic tool in the U.S. However, healthcare entities can still use it for research purposes. The lack of FDA approval has also not hindered sales of the Saphyr in other countries.
"Should I invest in Bionano Genomics stock?" "Should I trade "BNGO" stock today?"
According to our live Forecast System, Bionano Genomics Inc stock is an awesome long-term (1-year)...
What is the Bionano Genomics stock price / share price today?
The Bionano Genomics stock price is 2.395 USD today.
Will Bionano Genomics stock price grow / rise / go up?
Yes. The BNGO stock price can go up from 2.395 USD to 3.921 USD in...
Is it profitable to invest in Bionano Genomics stock?
Yes. The long-term earning potential is + 63.71 % in one year.
Will BNGO stock price fall / drop?
No. See above .
What will Bionano Genomics stock price be worth in five years (2027)?
The BNGO ("BNGO" ) future stock price will be 10.075 USD .
Will BNGO stock price crash?
According to our analysis, this will not happen.
Will Bionano Genomics stock price hit 10 USD price in a year?
Not within a year. See above .
Will Bionano Genomics stock price hit 20 USD price in a year?
Not within a year. See above .
Stock Price Forecast
Analyst Recommendations
The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 9.75, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +409.14% increase from the last price of 1.92.
